Portea Medical Pvt. Ltd, which offers healthcare services to patients at their homes, has tied up with US-based diagnostic device maker American Megatrends India Pvt. Ltd (AMI) to offer more personalized treatment for its home care patients in India.
Portea’s healthcare workers will use AMI’s B.O.L.T. health monitoring device—roughly the size of an iPhone—to collect health statistics from blood pressure to temperature from its patients. The data will then be used to personalize treatment plans and proactively intervene on a need basis.
The agreement between Portea and AMI is the first such partnership in the Indian home healthcare market, which is valued at $2-4 billion a year and growing at about 20% annually, according to the Bengaluru-based company backed by Ventureast, Accel Partners and Qualcomm Ventures.
Portea’s doctors will use the device to remotely monitor their patients’ health statistics on a real-time basis through an app. The device, which can currently collect data on blood pressure, pulse, blood oxygen levels and temperature, will be able to monitor patients’ cholesterol, glucose and anaemia levels in coming months.
“This data can help doctors and our staff to be alert and intervene when necessary, to avoid health complications. It would also be useful to offer personalized care. So far, such devices were not used by patients at home and were only available at hospitals or healthcare centres,” said Meena Ganesh, co-founder and chief executive of Portea Medical. “While this is our first such agreement, going forward we would invest a lot more in ramping up technology usage.”
The company has also started piloting the use of wearable technology and other medical devices to monitor diabetes, cardiovascular and respiratory disorders.
“Once we have established convincing results, we will introduce it to patients,” Ganesh said.
Portea, founded in 2012, claims to be the largest home healthcare provider with a patient base of around 35,000 in 24 cities. “Every month we tap around 50,000 visits and we see it growing four-five times in a year,” she said.
AMI’s Indian arm will manufacture the device in the country and sell it at around Rs.12,750 per device. Portea will get the device at a cheaper price tag of Rs.10,000 due to the partnership. AMI is also in talks with Apollo Hospitals, Nightingale Home healthcare among others.
Globally, patient monitoring devices are pegged to be growing at 5.5%. The growth is backed by a growing population of the elderly, lifestyle-related diseases and penetration of home care and remote monitoring.